cytosine has been researched along with Diffuse Mixed Small and Large Cell Lymphoma in 10 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Over an eight-month period from October 1997 to May 1998, four patients who had received bone marrow transplant (BMT) from unrelated donor presented with severe mucosal cutaneous infections involving acyclovir resistant herpes simplex virus 1 (HSV-1)." | 7.71 | Infection due to acyclovir resistant herpes simplex virus in patients undergoing allogeneic hematopoietic stem cell transplantation. ( Bordigoni, P; Carret, AS; Corsaro, D; Dauendorffer, JN; Edert, D; Le Faou, A; Venard, V, 2001) |
| " Nucleoside analogs in development for non-Hodgkin's lymphoma (NHL) include clofarabine, troxacitabine, and bendamustine, a hybrid of an alkylating nitrogen mustard group and a purine-like benzimidazole, with demonstrated activity in NHL." | 4.81 | Hematologic malignancies: new developments and future treatments. ( Cheson, BD, 2002) |
| "Over an eight-month period from October 1997 to May 1998, four patients who had received bone marrow transplant (BMT) from unrelated donor presented with severe mucosal cutaneous infections involving acyclovir resistant herpes simplex virus 1 (HSV-1)." | 3.71 | Infection due to acyclovir resistant herpes simplex virus in patients undergoing allogeneic hematopoietic stem cell transplantation. ( Bordigoni, P; Carret, AS; Corsaro, D; Dauendorffer, JN; Edert, D; Le Faou, A; Venard, V, 2001) |
| "By comparing the metabolism in mouse lymphosarcoma S49-wild type (S49-WT) and mutant cells deficient for dCMP deaminase, we identified the mono- and diphosphate metabolites generated from HPMP-5-azaC and its deaminated product HPMP-5-azaU." | 1.35 | Intracellular metabolism of the new antiviral compound 1-(S)-[3-hydroxy-2-(phosphonomethoxy)propyl]-5-azacytosine. ( Andrei, G; De Clercq, E; Holý, A; Krecmerová, M; Naesens, L; Neyts, J; Snoeck, R; Votruba, I, 2008) |
| "In the prostate cancer lines where MT-I was suppressed, glutathione-S-transferase-pi (GST-pi) was expressed." | 1.31 | Suppression of metallothionein-I/II expression and its probable molecular mechanisms. ( Ghoshal, K; Jacob, ST; Majumder, S, 2002) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (30.00) | 18.7374 |
| 1990's | 1 (10.00) | 18.2507 |
| 2000's | 6 (60.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Naesens, L | 1 |
| Andrei, G | 1 |
| Votruba, I | 1 |
| Krecmerová, M | 1 |
| Holý, A | 1 |
| Neyts, J | 1 |
| De Clercq, E | 1 |
| Snoeck, R | 1 |
| Cheson, BD | 1 |
| Jacob, ST | 1 |
| Majumder, S | 1 |
| Ghoshal, K | 1 |
| FURTH, JJ | 1 |
| HO, P | 1 |
| Luppi, M | 1 |
| Trovato, R | 1 |
| Barozzi, P | 1 |
| Vallisa, D | 1 |
| Rossi, G | 1 |
| Re, A | 1 |
| Ravazzini, L | 1 |
| Potenza, L | 1 |
| Riva, G | 1 |
| Morselli, M | 1 |
| Longo, G | 1 |
| Cavanna, L | 1 |
| Roncaglia, R | 1 |
| Torelli, G | 1 |
| Osswald, SS | 1 |
| Kulick, KB | 1 |
| Tomaszewski, MM | 1 |
| Sperling, LC | 1 |
| Witte, S | 1 |
| Goldenberg, DM | 1 |
| Haas, R | 1 |
| Moos, M | 1 |
| Karcher, A | 1 |
| Möhle, R | 1 |
| Witt, B | 1 |
| Goldschmidt, H | 1 |
| Flentje, M | 1 |
| Wannenmacher, M | 1 |
| Hunstein, W | 1 |
| Venard, V | 1 |
| Dauendorffer, JN | 1 |
| Carret, AS | 1 |
| Corsaro, D | 1 |
| Edert, D | 1 |
| Bordigoni, P | 1 |
| Le Faou, A | 1 |
| Marshak, A | 1 |
| Marshak, C | 1 |
1 review available for cytosine and Diffuse Mixed Small and Large Cell Lymphoma
| Article | Year |
|---|---|
Hematologic malignancies: new developments and future treatments.
Topics: Adenine Nucleotides; Alemtuzumab; Alkaloids; Antibodies, Monoclonal; Antibodies, Monoclonal, Humaniz | 2002 |
9 other studies available for cytosine and Diffuse Mixed Small and Large Cell Lymphoma
| Article | Year |
|---|---|
Intracellular metabolism of the new antiviral compound 1-(S)-[3-hydroxy-2-(phosphonomethoxy)propyl]-5-azacytosine.
Topics: Animals; Antiviral Agents; Cell Line, Tumor; Cidofovir; Cytosine; DNA Replication; DNA Viruses; DNA, | 2008 |
Suppression of metallothionein-I/II expression and its probable molecular mechanisms.
Topics: Animals; Carcinoma, Hepatocellular; CCAAT-Enhancer-Binding Proteins; Cytosine; DNA-Binding Proteins; | 2002 |
THE ENZYMATIC SYNTHESIS OF RIBONUCLEIC ACID IN ANIMAL TISSUE. I. THE DEOXYRIBONUCLEIC ACID-DIRECTED SYNTHESIS OF RIBONUCLEIC ACID AS CATALYZED BY AN ENZYME OBTAINED FROM BOVINE LYMPHOSARCOMA TISSUE.
Topics: Adenine; Animals; Catalysis; Cattle; Cytosine; DNA; DNA Replication; DNA, Bacterial; Enzootic Bovine | 1965 |
Treatment of herpesvirus associated primary effusion lymphoma with intracavity cidofovir.
Topics: Aged; Aged, 80 and over; Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Cell Survival; | 2005 |
Viral-associated trichodysplasia in a patient with lymphoma: a case report and review.
Topics: Administration, Topical; Aged; Alopecia; Antiviral Agents; Cidofovir; Cytosine; Facial Dermatoses; H | 2007 |
[First clinical studies with the antimetabolite cytosine arabinoside in chemotherapy of hemoblastoses and related diseases].
Topics: Blood Cell Count; Cytosine; Glycosides; Hematologic Diseases; Hodgkin Disease; Humans; Lymphoma, Non | 1967 |
[Sequential high-dose therapy in patients with low-malignity non-Hodgkin's lymphoma].
Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Cytarabine; Cytosine; Filgrastim; | 1995 |
Infection due to acyclovir resistant herpes simplex virus in patients undergoing allogeneic hematopoietic stem cell transplantation.
Topics: Acute Disease; Acyclovir; Adolescent; Amino Acid Substitution; Antiviral Agents; Bone Marrow Transpl | 2001 |
Nucleic acids of bovine lymphosarcoma and normal thymus.
Topics: Adenine; Animals; Carbon Isotopes; Cattle; Cytosine; DNA, Neoplasm; Electrophoresis; Guanine; Lympho | 1968 |